Publisher: Advanstar Communications, Inc.   (Total: 6 journals)   [Sort alphabetically]

Showing 1 - 7 of 7 Journals sorted by number of followers
Biopharm Intl.     Full-text available via subscription   (Followers: 20, SJR: 0.172, CiteScore: 0)
Applied Clinical Trials     Full-text available via subscription   (Followers: 7)
Pharmaceutical Technology     Full-text available via subscription   (Followers: 6, SJR: 0.127, CiteScore: 0)
Pharmaceutical Executive     Full-text available via subscription   (Followers: 6)
Contemporary OB GYN     Full-text available via subscription   (Followers: 4, SJR: 0.106, CiteScore: 0)
Contemporary Pediatrics     Full-text available via subscription   (Followers: 3)
Dermatology Times     Free  
Similar Journals
Journal Cover
Biopharm International
Journal Prestige (SJR): 0.172
Number of Followers: 20  
 
  Full-text available via subscription Subscription journal
ISSN (Print) 1542-166X
Published by Advanstar Communications, Inc. Homepage  [6 journals]
  • AbbVie and Cugene Form Autoimmune Disease Collaboration

    • Free pre-print version: Loading...

      Abstract: AbbVie and Cugene have reached an exclusive license option agreement for CUG252, Cugene’s lead therapeutic candidate.
      PubDate: Tue, 24 May 2022 16:05:00 +000
       
  • Vaxzevria Gains Approval in EU as a Third Dose COVID-19 Booster in Adults

    • Free pre-print version: Loading...

      Abstract: AstraZeneca's recombinant COVID-19 vaccine, originally invented by the University of Oxford, has been approved as a third dose booster vaccine in the EU.
      PubDate: Tue, 24 May 2022 13:46:37 +000
       
  • EMA Recommends Approval of Niemann-Pick Disease Types A/B and B Therapy

    • Free pre-print version: Loading...

      Abstract: EMA has recommended the marketing authorization of Xenpozyme (olipudase alfa) in the European Union.
      PubDate: Tue, 24 May 2022 13:42:13 +000
       
  • New Guidelines Aim to Advance Pediatric Drug Development

    • Free pre-print version: Loading...

      Abstract: A new initiative aims to speed the approval of and access to new drugs for young patients around the world, while limiting the number of children needed for testing in clinical trials.
      PubDate: Tue, 24 May 2022 13:42:00 +000
       
  • Pandemic Science Hub Launches at University of Edinburgh

    • Free pre-print version: Loading...

      Abstract: Investment has been made into a new science hub at the University of Edinburgh for the development of treatments for lung infections and future pandemics.
      PubDate: Tue, 24 May 2022 13:36:16 +000
       
  • INTERPHEX: May 24-26, 2022

    • Free pre-print version: Loading...

      Abstract: INTERPHEX will bring together industry professionals to discuss state-of-the-art solutions needed to cost effectively develop and manufacture quality product.
      PubDate: Tue, 24 May 2022 04:00:00 +000
       
  • AstraZeneca and RQ Biotechnology Sign License Agreement for Monoclonal
           Antibodies

    • Free pre-print version: Loading...

      Abstract: AstraZeneca has signed a license agreement with RQ Biotechnology for monoclonal antibodies to treat COVID-19.
      PubDate: Mon, 23 May 2022 20:10:00 +000
       
  • PTC Therapeutics Receives Positive Opinion for Upstaza

    • Free pre-print version: Loading...

      Abstract: PTC Therapeutics has received a positive opinion from EMA for Upstaza for the treatment of AADC deficiency.
      PubDate: Mon, 23 May 2022 20:05:00 +000
       
  • FDA Issues Labeling Guidance

    • Free pre-print version: Loading...

      Abstract: The final guidance addresses safety aspects of container and carton labeling design.
      PubDate: Mon, 23 May 2022 20:02:00 +000
       
  • Scalability Guide

    • Free pre-print version: Loading...

      Abstract: How to achieve scalable freezing & thawing of biopharmaceuticals
      PubDate: Mon, 23 May 2022 04:00:00 +000
       
  • High-Resolution LC-MS for Rapid Analysis of mRNA 5’ Capping and
           Poly-A Tailing

    • Free pre-print version: Loading...

      PubDate: Mon, 23 May 2022 04:00:00 +000
       
  • How Controlled Freezing Becomes Reality

    • Free pre-print version: Loading...

      Abstract: Impact of ice front growth speed on scalability of freezing protein solutions
      PubDate: Mon, 23 May 2022 04:00:00 +000
       
  • All-In-One Solution for Freezing and Thawing

    • Free pre-print version: Loading...

      Abstract: This brochure covers modular set up for scaling down to 1mL, scaling up to 300L, and the shaker function.
      PubDate: Mon, 23 May 2022 04:00:00 +000
       
  • FDA Stresses Risk Management Plans

    • Free pre-print version: Loading...

      Abstract: The agency is asking drug manufacturers to ensure a strong supply chain by developing risk management plans.
      PubDate: Fri, 20 May 2022 20:31:00 +000
       
  • Catalent Invests $175 Million to Expand Manufacturing Capabilities and
           Capacity in US Facility

    • Free pre-print version: Loading...

      Abstract: Catalent has announced a $175 million project to expand its manufacturing facility for large scale oral dose forms at its Winchester, Ky, site.
      PubDate: Fri, 20 May 2022 13:14:02 +000
       
  • FDA Approves Lilly’s Novel, Dual-Targeted Treatment for Type 2
           Diabetes

    • Free pre-print version: Loading...

      Abstract: FDA has approved Mounjaro (tirzepatide) injections as a treatment to improve blood sugar control in adults with type 2 diabetes.
      PubDate: Fri, 20 May 2022 13:12:09 +000
       
  • Laying the Foundation for Smart Manufacturing While Solving Today’s
           Tough Challenges

    • Free pre-print version: Loading...

      PubDate: Fri, 20 May 2022 04:00:00 +000
       
  • Balancing Internal Focus Against External Capabilities

    • Free pre-print version: Loading...

      Abstract: Demand for outsourced services of technical R&D activities is increasing.
      PubDate: Thu, 19 May 2022 19:13:00 +000
       
  • Catalent OneBio® Suite

    • Free pre-print version: Loading...

      Abstract: OneBio® Suite is an integrated solution for biologics development that reduces timelines, risk and complexity.
      PubDate: Thu, 19 May 2022 14:38:00 +000
       
  • WuXi Biologics - Global CRDMO

    • Free pre-print version: Loading...

      Abstract: WuXi biologics provides end-to-end biologics and vaccines solutions.
      PubDate: Thu, 19 May 2022 14:30:00 +000
       
  • Post-curing on the reduction of cyclosiloxanes v3

    • Free pre-print version: Loading...

      Abstract: Watson Marlow Fluid Technologies Solutions (WMFTS), fluid path solutions provider of peristaltic pumps and single-use component, outlines the results of a study which makes comparisons between the semi volatiles extractables profile of post-cured and non post-cured samples of its Pumpsil platinum-cured silicone tubing.
      PubDate: Thu, 19 May 2022 04:00:00 +000
       
  • Effective Removal of Endotoxins with TOYOPEARL® NH2-750F

    • Free pre-print version: Loading...

      Abstract: Reduce endotoxins in a sample to levels below the limit of detection for a LAL assay with an anion exchange resin in a flow-through chromatography mode.
      PubDate: Thu, 19 May 2022 04:00:00 +000
       
  • Pfizer and BioNTech Granted EUA for Booster Dose of COVID-19 Vaccine in
           Young Children

    • Free pre-print version: Loading...

      Abstract: Pfizer and BioNTech’s COVID-19 vaccine has been granted EUA for booster doses in children five through 11 years of age.
      PubDate: Wed, 18 May 2022 19:19:00 +000
       
  • Pfizer and BioNTech Update COVID-19 Vaccine Supply Agreement with EC

    • Free pre-print version: Loading...

      Abstract: The companies have reached an agreement with the European Commission to update their COVID-19 vaccine supply agreement.
      PubDate: Wed, 18 May 2022 19:12:00 +000
       
  • The Ever-Changing World of Extractables and Leachables, Part 4, A Free
           Virtual Conference

    • Free pre-print version: Loading...

      Abstract: Wednesday, May 18th, 2022 at 3pm BST 10am EDT 4pm CEST 7am PDTJoin global industry and regulatory experts as they discuss current E&L hot topics on pharmaceuticals, biopharmaceuticals and medical devices.
      PubDate: Wed, 18 May 2022 09:00:00 +000
       
  • AAE-MS™ as an Orthogonal Method in Host Cell Protein Analytics

    • Free pre-print version: Loading...

      PubDate: Tue, 17 May 2022 04:00:00 +000
       
  • Introduction to Multi-Column Continuous Chromatography and How it Can
           Increase Productivity for mAb Production up to Kilogram Scale

    • Free pre-print version: Loading...

      Abstract: Tuesday, May 17, 2022 at 9 AM EDT 6am PDT 2pm BST 3pm CESTTuesday, May 17, 2022 at 2 PM EDT 11am PDT 7pm BST 8pm CESTIncrease productivity and reduce costs for mAb purification. Learn how multi-column continuous chromatography can improve your mAb purification workflow.
      PubDate: Tue, 17 May 2022 04:00:00 +000
       
  • Pfizer to Acquire Biohaven Pharmaceuticals for $11.7 Billion

    • Free pre-print version: Loading...

      Abstract: Pfizer will acquire Biohaven Pharmaceuticals, a clinical-stage biopharmaceutical company specializing in migraine treatments, for $11.7 billion.
      PubDate: Mon, 16 May 2022 18:52:55 +000
       
  • Avacta Establishes New Therapeutics Headquarters

    • Free pre-print version: Loading...

      Abstract: Avacta is relocating its therapeutics headquarters to Scale Space in Imperial College’s White City Campus, London, United Kingdom.
      PubDate: Mon, 16 May 2022 18:51:50 +000
       
  • Direct LC-MS Characterization of Glycoform Distribution and Low Molecular
           Weight Impurities in mAb Process

    • Free pre-print version: Loading...

      Abstract: Using the BioAccord LC-MS System and an Ambr® 15, we developed an analytical method for rapid mAb glycoform confirmations and mAb purity assessments. This unique method is high throughput capable and has the potential to be a fully automated platform for mid-process intraday monitoring of CQAs.
      PubDate: Mon, 16 May 2022 04:00:00 +000
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.235.176.80
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-